- Home
- MDAI vs RDI Comparison
MDAI vs RDI Comparison
Compare MDAI & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- RDI
- Stock Information
- Founded
- MDAI 2013
- RDI 1937
- Country
- MDAI United States
- RDI United States
- Employees
- MDAI N/A
- RDI N/A
- Industry
- MDAI Medical/Dental Instruments
- RDI Movies/Entertainment
- Sector
- MDAI Health Care
- RDI Consumer Discretionary
- Exchange
- MDAI Nasdaq
- RDI Nasdaq
- Market Cap
- MDAI 27.8M
- RDI 30.1M
- IPO Year
- MDAI N/A
- RDI N/A
- Fundamental
- Price
- MDAI $1.29
- RDI $1.31
- Analyst Decision
- MDAI Strong Buy
- RDI Hold
- Analyst Count
- MDAI 2
- RDI 1
- Target Price
- MDAI $4.75
- RDI $2.40
- AVG Volume (30 Days)
- MDAI 426.7K
- RDI 46.2K
- Earning Date
- MDAI 05-06-2025
- RDI 03-31-2025
- Dividend Yield
- MDAI N/A
- RDI N/A
- EPS Growth
- MDAI N/A
- RDI N/A
- EPS
- MDAI N/A
- RDI N/A
- Revenue
- MDAI $29,581,000.00
- RDI $210,527,000.00
- Revenue This Year
- MDAI N/A
- RDI $16.31
- Revenue Next Year
- MDAI $49.47
- RDI $6.78
- P/E Ratio
- MDAI N/A
- RDI N/A
- Revenue Growth
- MDAI 63.83
- RDI N/A
- 52 Week Low
- MDAI $0.82
- RDI $1.22
- 52 Week High
- MDAI $3.25
- RDI $1.90
- Technical
- Relative Strength Index (RSI)
- MDAI 39.65
- RDI 43.93
- Support Level
- MDAI $1.04
- RDI $1.23
- Resistance Level
- MDAI $1.76
- RDI $1.49
- Average True Range (ATR)
- MDAI 0.16
- RDI 0.11
- MACD
- MDAI -0.02
- RDI 0.00
- Stochastic Oscillator
- MDAI 31.65
- RDI 22.86
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.